BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Study: Survivors of Severe COVID-19 at Higher Mortality Risk and More Research

  Research continues to reveal how COVID-19 affects different people with different health issues, both short-term and long-term.

  December 2, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  Research Roundup: A Potential Cause of Alzheimer’s Disease and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  December 2, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  BeyondSpring is Going Back to the Drawing Board with CIN Prevention Asset

  In the CRL, the FDA indicated that the single registrational trial (106 Phase III) did not provide sufficient proof of efficacy to demonstrate benefit.

  December 2, 2021

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Business

  Astellas Hopes to Improve Gene Therapy Safety with $1.6 Billion Dyno Deal

  With this new collaboration, Astellas will take advantage of Dynos’ next-gen AAV vectors to deliver its gene therapy.

  December 2, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Pharm Country

  GSK Shares Positive Omicron Update, New Oxford Partnership

  GlaxoSmithKline said early research shows its monoclonal antibody is demonstrating efficacy against the newest strain of COVID-19.

  December 2, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Amgen’s Otezla Shines Again in Psoriasis

  The Phase III DISCREET study evaluated the efficacy of Otezla in adults who have been diagnosed with moderate to severe plaque psoriasis and genital psoriasis.

  December 2, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Study: Isomers May Hold New Clue to Alzheimer’s Disease

  Researchers studied the behavior of protein cells in the brain and found a significant difference in those who have had dementia and those who have not, particularly in their ability to clean themselves.

  December 2, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Policy

  BMS Faces Heat from Employees Over Vaccine Mandate

  Four BMS employees have filed a lawsuit against BMS after claiming the company would not grant them a religious exemption and threatened their employment.

  December 2, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Tune Therapeutics Debuts with $40 Million to Fine-Tune the Human Genome

  Tune claims TEMPO can rapidly target and adjust the epigenomic machinery, controlling gene expression and dictating how the DNA will be molded.

  December 2, 2021

   · 

  2 min read

   · 

  Rosey Alba
• 

  Business

  Mix-and-Match Vaccine Platform May Boost Immune Response & Duration

  IDRI is working with a newly-formed consortium to develop a next-gen COVID-19 vaccine that will be stable at routine temperatures and that may be able to confer immunity for a longer duration.

  December 2, 2021

   · 

  4 min read

   · 

  Gail Dutton